Skip to main content
VCbacked
Log inGet Started

The Patient Company

Grand Rapids, United States

Patient Company provides clinical staff members with an automated lateral patient transfer device.

$3.3M raised
Aug 2023
Series A
Health CareMedicalMedical Device

Top Investors

Michigan RiseRed Cedar VenturesMayo Clinic VenturesTech Startup Stabilization FundConquer Accelerator

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about The Patient Company

How much funding has The Patient Company raised?
The Patient Company has raised $3.3M in total funding. The most recent round was Series A. The last funding was announced in August 2023.
Who are The Patient Company's investors?
The Patient Company's investors include Michigan Rise, Red Cedar Ventures, Mayo Clinic Ventures, Tech Startup Stabilization Fund, Conquer Accelerator.
Where is The Patient Company headquartered?
The Patient Company is headquartered in Grand Rapids, United States.
What does The Patient Company do?
Patient Company provides clinical staff members with an automated lateral patient transfer device.
What stage is The Patient Company at?
The Patient Company is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"The Patient Company — Funding & Investors." VCBacked, August 31, 2023, https://www.vcbacked.co/company/the-patient-company. Accessed June 5, 2026.
APA
VCBacked. (2023). The Patient Company — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/the-patient-company
Wikipedia (cite web)
{{cite web |title=The Patient Company — Funding & Investors |url=https://www.vcbacked.co/company/the-patient-company |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K